11-2583546-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000218.3(KCNQ1):c.1032+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000218.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.1032+1G>A | splice_donor_variant, intron_variant | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.1032+1G>A | splice_donor_variant, intron_variant | 1 | NM_000218.3 | ENSP00000155840.2 | ||||
KCNQ1 | ENST00000335475.6 | c.651+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000334497.5 | |||||
KCNQ1 | ENST00000496887.7 | c.771+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000434560.2 | |||||
KCNQ1 | ENST00000646564.2 | c.588+1G>A | splice_donor_variant, intron_variant | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1456396Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 724854
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74344
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:2
Likely pathogenic, no assertion criteria provided | research | Medical Research Institute, Tokyo Medical and Dental University | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 16, 2023 | This sequence change affects a donor splice site in intron 7 of the KCNQ1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in KCNQ1 are known to be pathogenic (PMID: 9323054, 19862833). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with long QT syndrome (PMID: 16244680, 19716085, 26132555, 34319147, 34505893). ClinVar contains an entry for this variant (Variation ID: 52937). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2023 | Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 16244680, 19716085, 18752142, 19862833, 34319147, 34505893, 26132555) - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 29, 2022 | The c.1032+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 7 of the KCNQ1 gene. This alteration has been reported in subjects with features of long QT syndrome (LQTS) and was shown to segregate with disease in one family (Kapplinger JD et al. Heart Rhythm, 2009 Sep;6:1297-303; Shigemizu D et al. PLoS One, 2015 Jul;10:e0130329; Choi SH et al. Circ Genom Precis Med, 2021 Aug;14:e003300). Another alteration impacting the same site (c.1032G>A (p.A344A)) has been shown to have a similar impact on splicing (Wuriyanghai Y et al. Heart Rhythm, 2018 Oct;15:1566-1574). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and will result in the creation or strengthening of a novel splice donor site. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at